Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-06-10 00:00:00 ET · period of report 2025-06-09 · accession 0000950170-25-084556 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-06-10 | 2025-06-09 | AXSM | Jacobson Mark L. | COO | M - OptEx | $8.02 | +25.0K | 30.8K | +432% | +$200.5K |
| DT | 2025-06-10 | 2025-06-09 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $110.44 | -25.0K | 5,783 | -81% | -$2.76M |
| DT | 2025-06-10 | 2025-06-09 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-09 | M | A | 25,000 | $8.02 | 30,783 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-09 | S | D | 25,000 | $110.44 | 5,783 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $108.27 and $112.24. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-06-09 | M | D | 25,000 | $0.00 | 0 | D | $8.02 · 2017-05-27 to 2026-05-27 | 25,000 Common Stock |